You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2025

Details for Patent: 10,688,047


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,688,047 protect, and when does it expire?

Patent 10,688,047 protects DUVYZAT and is included in one NDA.

This patent has thirty-six patent family members in thirty countries.

Summary for Patent: 10,688,047
Title:Physically and chemically stable oral suspensions of givinostat
Abstract:Physically and chemically stable oral liquid formulations of Givinostat (Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form of aqueous suspensions and contain Givinostat and/or pharmaceutically acceptable salts and/or derivatives thereof, at least a wetting agent and/or at least a density-imparting agent. Such formulations are suitable for oral administration for systemic therapeutic action.
Inventor(s):Colombo Giuseppe, Artico Roberta, Mascagni Paolo, Monzani Maria Valmen, Puccianti Silvia
Assignee:ITALFARMACO SPA
Application Number:US15770443
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

United States Patent 10,688,047: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

Understanding the scope, claims, and patent landscape of a specific patent is crucial for companies to protect their intellectual property, identify gaps in coverage, and strategize future innovations. This article provides a comprehensive analysis of United States Patent 10,688,047, focusing on its claims, scope, and the broader patent landscape.

Patent Overview

Patent Number and Title

United States Patent 10,688,047 is a patent that has been granted for a specific invention. While the exact title of the patent is not provided in the sources, it is essential to identify the title and the general subject matter to understand its scope.

Inventors and Assignees

Identifying the inventors and assignees of the patent is vital. This information can be found in the patent document and is crucial for understanding the ownership and potential licensing or collaboration opportunities.

Claims Analysis

Claim Structure

Patent claims are the most critical part of any patent application, as they define the scope of protection. Claims in a patent like 10,688,047 can be categorized into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details[3].

Claim Coverage Matrix

To analyze the claims effectively, a Claim Coverage Matrix can be used. This matrix categorizes claims by their scope concepts, allowing for a comprehensive understanding of which patents and claims are actively protecting the intellectual property. This method helps in identifying gaps or opportunities in the current claim coverage[3].

Scope Concepts

The claims of Patent 10,688,047 should be categorized by overarching scope concepts. These concepts help in filtering, searching, and analyzing large numbers of patent claims concurrently. This categorization can highlight high-value claims that are crucial to the company’s current operations, medium-value claims indicating potential future directions, and low-value claims that may not be worth maintaining[3].

Scope of the Patent

Subject Matter

To determine the scope of the patent, it is necessary to understand the subject matter it covers. The patent must satisfy the requirements of being useful, novel, and nonobvious, and it must claim patentable subject matter. The utility requirement is met if the invention is operable and provides some tangible benefit. Novelty is established if the invention is not fully anticipated by prior art, and nonobviousness is determined if the invention was not readily within the ordinary skills of a competent artisan at the time it was made[4].

Prior Art Analysis

A thorough analysis of prior art is essential to understand the novelty and nonobviousness of the invention claimed in Patent 10,688,047. This involves reviewing existing patents, publications, and other state of the art knowledge to ensure that the invention is distinct and innovative.

Patent Landscape

Family of Patents

Understanding if Patent 10,688,047 is part of a family of patents is crucial. This involves identifying whether it is a continuation, continuation-in-part, or divisional application of an earlier patent. For example, in the case of the Cellect patents, each member of the family had different expiration dates due to Patent Term Adjustments (PTA), which can impact the overall patent landscape[1].

Patent Term Adjustments (PTA)

PTA can significantly affect the expiration date of a patent. It is important to determine if Patent 10,688,047 has been granted PTA and how this affects its expiration date. This is particularly relevant in cases where obviousness-type double patenting (ODP) analyses are performed, as seen in the Cellect case[1].

Obviousness-Type Double Patenting (ODP)

ODP is a critical consideration in the patent landscape. It prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA. Ensuring that ODP analyses are conducted correctly is essential to avoid invalidation of claims[1].

Claim Charts and Technical Review

Interactive Claim Charts

Using interactive claim charts generated by software like ClaimScape® can help in reviewing patent coverage with engineers, scientists, and management. These charts facilitate the identification of whether a particular scope concept is applicable to a target product or method, highlighting gaps in current coverage and future design opportunities[3].

Technical Expert Review

Technical experts should review the claims and scope concepts to determine their applicability and value. This review helps in identifying areas where the company lacks necessary claim coverage and in spotting future design options.

Strategic Implications

Identifying Gaps and Opportunities

The analysis of Patent 10,688,047 should highlight any gaps in the current claim coverage. Identifying these gaps allows the company to strategize and file new patent applications to cover critical areas of technology.

Future Design Options

The claim charts and scope concepts analysis can also reveal future design options. By understanding the high-value claims and potential future directions, the company can align its research and development efforts with its intellectual property strategy.

Risk Management

Divided Ownership and Harassment

Ensuring that the patent does not pose a risk of divided ownership or harassment by multiple assignees is important. This can be managed through careful assignment and licensing agreements, as well as ensuring that terminal disclaimers are used appropriately to overcome ODP rejections[1].

Key Takeaways

  • Claims Analysis: Understanding the structure and scope of claims in Patent 10,688,047 is crucial for determining the protection it offers.
  • Scope Concepts: Categorizing claims by scope concepts helps in identifying high-value, medium-value, and low-value claims.
  • Patent Landscape: Analyzing the patent family, PTA, and ODP is essential for understanding the patent’s expiration date and validity.
  • Technical Review: Involving technical experts in reviewing claim charts ensures accurate identification of gaps and opportunities.
  • Strategic Implications: Identifying gaps and future design options helps in aligning R&D efforts with intellectual property strategy.

FAQs

Q: What is the importance of analyzing the claims of a patent like 10,688,047?

A: Analyzing the claims helps in understanding the scope of protection, identifying gaps in coverage, and strategizing future innovations.

Q: How does Patent Term Adjustment (PTA) affect the expiration date of a patent?

A: PTA can extend the term of a patent due to delays in the prosecution process, but it does not extend the term past the date of a terminal disclaimer.

Q: What is obviousness-type double patenting (ODP), and why is it important?

A: ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent filed at the same time but with a different patent term due to PTA.

Q: How can interactive claim charts help in reviewing patent coverage?

A: Interactive claim charts facilitate the review of patent coverage with technical experts, helping to identify gaps in current coverage and future design opportunities.

Q: Why is it important to involve technical experts in reviewing patent claims?

A: Technical experts can accurately determine the applicability and value of the claims, helping to identify areas where the company lacks necessary claim coverage and spotting future design options.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. Drug Patent Watch - Patent 10,688,047
  3. Schwegman, Lundberg & Woessner, P.A. - Patent Analytics
  4. CRS Reports - Patents and Innovation Policy
  5. Food and Drug Administration - CDER, Office of Regulatory Policy

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,688,047

Showing 1 to 1 of 1 entries

International Family Members for US Patent 10,688,047

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 106559 ⤷  Try for Free
Australia 2016349169 ⤷  Try for Free
Brazil 112018008870 ⤷  Try for Free
Brazil 122024001653 ⤷  Try for Free
Canada 3002755 ⤷  Try for Free
Chile 2018001151 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.